SCHEMBL8738447

SCHEMBL8738447

NCCCOCCCCOCCCCOCCCCOCCCCOCCCN

nearest known ligand 0.92

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ODC1 P11926 1/20 0.53
NFKB1 P19838 1/20 0.43
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA3 P07451 2/20 0.40
CA4 P22748 2/20 0.40
CA6 P23280 2/20 0.40
CA5A P35218 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40
CA5B Q9Y2D0 2/20 0.40
DNM1 Q05193 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40
BLM P54132 1/20 0.40
CYP3A4 P08684 1/20 0.39
HTT P42858 2/20 0.32
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6749221 1.00 ODC1 (0.53) ODC1NFKB1CA12CA1CA2
SCHEMBL64270 1.00 ODC1 (0.53) ODC1NFKB1CA12CA1CA2
Ethylenediamine SCHEMBL10796877 1.00 ODC1 (0.53) ODC1NFKB1CA12CA1CA2
SCHEMBL18166488 1.00 ODC1 (0.53) ODC1NFKB1CA12CA1CA2
SCHEMBL9812321 0.96 NFKB1 (0.50) ODC1NFKB1CA12CA1CA2
SCHEMBL816340 0.96 ODC1 (0.50) ODC1NFKB1CA12CA1CA2
SCHEMBL9748007 0.96 ODC1 (0.50) ODC1NFKB1CA12CA1CA2
SCHEMBL17188316 0.96 ODC1 (0.50) ODC1NFKB1CA12CA1CA2
SCHEMBL2311533 0.96 ODC1 (0.50) ODC1NFKB1CA12CA1CA2
SCHEMBL1344404 0.96 ODC1 (0.50) ODC1NFKB1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180177881-A1 Multicomponent Degradable Cationic Polymers THE JOHNS HOPKINS UNIVERSITY 2018-06-28 US disclosed
US-9884118-B2 Multicomponent degradable cationic polymers THE JOHNS HOPKINS UNIVERSITY (US) 2018-02-06 US disclosed
US-20180028455-A1 PEPTIDE/PARTICLE DELIVERY SYSTEMS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-02-01 US disclosed
US-20170143639-A1 NANOCOMPOSITES OF GOLD AND POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2017-05-25 US disclosed
US-20150273071-A1 Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery THE JOHNS HOPKINS UNIVERSITY (US) 2015-10-01 US disclosed
US-20150272900-A1 Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics THE JOHNS HOPKINS UNIVERSITY 2015-10-01 US disclosed
US-20150250881-A1 Multicomponent Degradable Cationic Polymers THE JOHNS HOPKINS UNIVERSITY (US) 2015-09-10 US disclosed
US-8992991-B2 Multicomponent degradable cationic polymers THE JOHNS HOPKINS UNIVERSITY (US) 2015-03-31 US disclosed
US-20140294909-A1 NANOCOMPOSITES OF GOLD AND POLYMERS THE JOHNS HOPKINS UNIVERSITY (US) 2014-10-02 US disclosed
US-20120128782-A1 Multicomponent Degradable Cationic Polymers THE JOHNS HOPKINS UNIVERSITY (US) 2012-05-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150272900-A1 Layer-By-Layer Approach to Co-Deliver DNA and siRNA via AuNPs: A Potential Platform for Modifying Release Kinetics DNMT3L, DBNL, HNRNPL ODC1 3657/4885NFKB1 4012/4885CA12 1280/4885
US-20150250881-A1 Multicomponent Degradable Cationic Polymers PEF1, FIBP, PARN ODC1 625/4885NFKB1 2868/4885CA12 4148/4885
US-20180177881-A1 Multicomponent Degradable Cationic Polymers PEF1, FIBP, PARN ODC1 625/4885NFKB1 2868/4885CA12 4148/4885
US-20170143639-A1 NANOCOMPOSITES OF GOLD AND POLYMERS HNRNPL, HNRNPLL, ACSL3 ODC1 3530/4885NFKB1 4181/4885CA12 943/4885
US-20150273071-A1 Bioreducible Poly (Beta-Amino Ester)s For siRNA Delivery AARS1, SLC43A1, PHAX ODC1 3141/4885NFKB1 1704/4885CA12 3913/4885
US-20120128782-A1 Multicomponent Degradable Cationic Polymers PEF1, FIBP, PARN ODC1 625/4885NFKB1 2868/4885CA12 4148/4885
US-20180028455-A1 PEPTIDE/PARTICLE DELIVERY SYSTEMS VEGFA, IAPP, FLT1 ODC1 4229/4885NFKB1 1494/4885CA12 3706/4885
US-20140294909-A1 NANOCOMPOSITES OF GOLD AND POLYMERS HNRNPL, HNRNPLL, ACSL3 ODC1 3530/4885NFKB1 4181/4885CA12 943/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.